The 10-year survival rate for patients with stage III colon cancer is about 30% after treatment, which can vary.
Colon cancer is a common malignant tumor, which is caused by a variety of factors such as heredity and gene mutation. Stage III may include various situations, such as tumor invasion of submucosa or intrinsic muscle layer, metastasis in 1~3 regional lymph nodes, no distant metastasis, etc. At this time, if there is a chance of surgery, it can be performed first.
At this time, if there is a chance of surgery, preoperative neoadjuvant chemotherapy can be carried out to increase the surgical resection rate; postoperative treatment can be supplemented with radiotherapy, targeted therapy and other therapies. If there is no chance of surgery, non-surgical therapies such as radiotherapy, targeted therapy and immunotherapy can be performed directly. After active treatment, patients can obtain a 10-year survival rate of about 30%.